BiotechTube
Home/Serodus/Arnstein Endresen
AE

Arnstein Endresen

Board Member

Serodus

Therapeutic Areas

NephrologyMetabolic Disease

Serodus Pipeline

DrugIndicationPhase
SER150Diabetic Kidney Disease in Type 2 DiabetesPhase 2
SER140Diabetic Kidney Disease in Type 2 DiabetesPhase 1

Leadership Team at Serodus

DE
Dr. Eva Steiness
Chief Executive Officer
HM
Henrik Mordhorst
Chief Financial Officer
DC
Daniel Capion
Business Development and Documentation
SE
Søren Elmann Ingerslev
Chairman of the Board
TS
Terri Sebree
Board Member
VG
Viggo G. Harboe
Board Member
LB
Lars Beck-Thomsen
Board Member
View full Serodus profile